Objective: Relatives of individuals with Crohn's disease (CD) carry an increased number of CD-associated genetic variants and are at increased risk of developing the disease. Multiple environmental and genetic factors contribute to this increased risk.
Introduction
Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory condition of the gastrointestinal tract associated with significant morbidity. Family members of individuals with CD are at increased risk for developing the disease. Estimates of the sibling relative risk (the ratio of disease risk in siblings compared with the rate in the general population) range from 15 to 42 1 . A retrospective study of the entire Danish population over a period of more than 40 years found that about 12% of new incidents of CD occurred in families already affected by the disease 2 . Disease onset precedes the development of symptoms, which often precede diagnosis by months to years, at which stage many patients have developed complications of the disease (including malnutrition, osteoporosis, and strictures or fistulas requiring surgery) 3 . There is emerging evidence to support the use of immunosuppressive treatment early in the course of CD to reduce the risk of such complications 4 . With an increasing incidence and prevalence of IBD worldwide 5 , a clinical tool that facilitates early detection of those at greatest risk opens up the possibility for early intervention to alter or halt aberrant immune and inflammatory responses before the development of overt disease, and perhaps, ultimately, disease prevention.
Although CD pathogenesis remains incompletely understood, genetic risk for the disease is well-established. Heritability, the proportion of population trait variance explained by genetic factors, estimated from identical and non-identical twin concordance rates, is 0.75 6 . Genetic variance explained by CD-associated loci discovered through genome-wide association studies (GWAS), so-called SNP heritability, is 0.37, indicating that approximately half the total CD heritability is explained by known SNPs 6 . To date, there are 240 single nucleotide polymorphisms (SNPs) robustly associated with the IBD 7 . A recent study of first-degree relatives (FDRs) of patients with IBD showed that they are enriched for IBD-associated risk loci 8 .
Familial clustering of disease is likely the result of shared environmental factors, as well as genetic risk factors. The observed increasing incidence of the disease among populations with historically lower rates, and those migrating from regions with low incidence rates to regions with higher rates, is consistent with a substantial environmental risk component to CD 5 . Many lifestyle-related factors have been implicated, including stress, sedentary lifestyle, western diet, poor sleep, and tobacco use 9 10 . Smoking is the best-studied environmental risk factor; a metaanalysis estimated a two-fold risk increase for CD in current smokers 11 .
Asymptomatic FDRs may display phenotypic features in common with CD patients including altered intestinal permeability, positive serological antimicrobial markers, disordered innate and acquired immunity, faecal dysbiosis, and elevated faecal calprotectin (FC) 12 . Overt small intestinal (SI) inflammation has been described in FDRs who have undergone ileocolonoscopy 13 , intestinal ultrasound 14 and video capsule endoscopy (VCE) 15 .
Evidence of increased risk factors for CD in FDRs raises the possibility of predicting those at risk of developing the disease 12 . We hypothesized that the observed increase in the number of CD-associated risk loci in FDRs relative to healthy controls 8 , elevated levels of FC 12 , and smoking status, taken together could provide sufficient information to detect at-risk individuals before the development of overt symptoms. In this study we aimed to assess the clinical utility of a disease risk model to predict the presence of SI inflammation as detected by VCE. We applied two machine learning methods to genetic risk (72 genetic markers), smoking status, number of relatives with CD, 22 biomarkers, and assessed the predictive ability of the derived models.
Material and Methods

Participants
We recruited 480 healthy FDRs (full siblings, offspring or parents) between the age of 18 and 55, through patients with CD attending the IBD service at Guy's & St Thomas' NHS Foundation Trust (GSTT) and members of Crohn's & Colitis UK (a charity supporting patients with IBD). CD diagnosis in probands was confirmed by their gastroenterologist or general practitioner. Interested FDRs provided information regarding family history of IBD, medical history (including gastrointestinal symptoms), smoking status, medication use, allergies, primary care provider and ethnicity. In keeping with the population of the meta-analysis of CD GWAS used for calculating the genotype relative risk 16 , only FDRs of European ancestry were included. The inclusion criteria were: ability to give written informed 6 consent, age 18-55 years, confirmed history of Crohn's disease in the proband, and absence of gastrointestinal symptoms in the FDR. The exclusion criteria were: a previous diagnosis of IBD, a previous diagnosis of irritable bowel syndrome, or presence of a major co-morbidity. Additional exclusion criteria for capsule endoscopy were: pregnancy, major bowel surgery, or the use of non-steroidal antiinflammatory drugs in the 4 weeks prior to capsule endoscopy (low-dose aspirin excluded).
DNA collection and genotyping
480 FDRs met the inclusion criteria and were sent a saliva sampling kit (Oragene™ DNA OG-500) and 455 returned saliva samples. DNA extraction and genotyping protocols are included in the supplementary materials. DNA samples were genotyped on the Immunochip, which is a custom Illumina Infinium array containing 196,524 SNPs and small insertion/deletions selected mainly from GWAS analysis of 12 immune-mediated diseases 17 . It included all SNPs from CD-associated loci at the time of design. The three major NOD2 variants were analysed separately (rs2066844, rs2066845 and rs2066847), instead of the NOD2 tagging SNP, rs2076756. Owing to the enhanced risk of homozygotes and compound heterozygotes for NOD2 variants, the NOD2 variants were combined, rather than treated as independent loci.
Genotypes for a total of 72 SNPs from known CD risk loci were extracted for genetic risk profiling.
The relevant SNP data were extracted and underwent quality control (QC) in PLINK 18 .
SNPs with missingness >3% and Hardy-Weinberg equilibrium outliers (p ≤ 1 x 10 -4 ) were excluded. X chromosome heterozygosity rates were used to determine sex empirically. Population structure was assessed by principal components analysis in PLINK as previously described 19 , derived from CEU HapMap 3 individuals (Northern and Western European Ancestry). No outliers were identified.
Following QC, 11 saliva samples were repeated due to a low DNA concentration or quality, one of which repeatedly failed QC and was excluded. 454 FDRs were successfully genotyped (61% female; median age 34, range 18-55; 40% were siblings, 46% offspring, 14% parents of probands; 44% were current or ex-smokers).
Calculation of high and low risk groups
We generated a combined smoking and genotype risk score in 454 FDRs of individuals with CD using the R package REGENT 22 . Summary results were obtained for 72 genetic variants from GWAS meta-analysis in CD 16 . Smoking risk was calculated using ORs from a large case-control study 23 . 147 FDRs in the highest and lowest risk quartiles of the risk score were invited to undergo VCE, and to provide stool and blood samples for biomarker analysis.
Subsequent statistical analyses were performed on the subset of 124 participants for whom we had complete data on all measures (age in years (mean=37.42, sd=10.46), sex (male=42, female=82), and genetic risk score and smoking were considered in the modelling as separate variables.
Smoking status was recorded as "Current", "Ex", or "Never" smoked (29, 33, 62 respectively among 124 individuals with complete data). We used "Never" smoked as the reference level. The number of family members with CD (CD family history) was coded as "single" or "multiple" (111, 13 respectively among 124 individuals with complete data).
Video capsule endoscopy (VCE)
Capsule endoscopies were performed in the Endoscopy Unit at GSTT following written informed consent. The MiroCam™ (Intromedic, Seoul, Korea) VCE system was used for all capsule endoscopies (see supplementary materials for full description and protocol). Two validated scoring systems were used to quantify the degree of inflammation within the small intestine: the Lewis Score 20 and the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI) 21 . SI transit time was defined as the passage from the first duodenal to the first caecal image, in minutes.
Biomarkers
Full biomarker description and protocol are included in the supplementary materials.Stool was analysed for faecal calprotectin and serum for high-sensitivity Creactive protein (hs-CRP), anti-saccharomyces cerevisiae antibodies (ASCA), and cytokines and growth factors. Table 1 shows the descriptive statistics for the complete list of 22 biomarkers measured. We dropped from the statistical analyses, 6/22 biomarkers with near zero variance among the 124 individuals with complete data. 
Statistical analysis
All statistical analyses were performed in the R programming language and environment 24 . For the predictive modelling we used the R package caret 25 , and its dependencies glmnet 26 and ranger 27 .
Explanatory modelling
We first fitted multivariate logistic regression models with dichotomized Lewis score Given that the ultimate aim of the study was to estimate the utility of the genetic, environmental and biomarker variables to identify high risk individuals, we went on to derive a series of predictive models. Machine learning is specifically designed to deal with the large number of variables relative to sample size problem, and includes techniques to address the low events-per-variable ratio (small number of cases).
Predictive modelling
Our goal was to develop a predictive model for SI inflammation, achieving a balance between interpretability (by reducing the number of predictor variables) and predictive ability. Thus we used machine learning, which has techniques for variable subset selection and estimation of how well a given model will perform at predicting future data 29 . Machine learning finds structure in data and addresses over-fitting when there are a large number of predictors. More generally, it is a set of techniques that improve performance on a specified task (e.g. classifying absence/presence of inflammation) with experience (exposure to data). We divided the data into a test sample is then pass through each tree, and is assigned the (majority) class of the leaf on which it lands. Every tree in the forest produces a prediction and these predictions are combined to give a single consensus prediction for the individual 28 29 .
We used 20 repeats of 5-fold cross validation on the training data to select the optimum number of randomly selected predictors (mtry) that maximized the AUC.
Overall variable importance was determined by permuting predictors one at a time and measuring the mean decrease in accuracy averaged over all trees.
These two predictive modelling techniques, as well as more general statistical modelling and machine learning considerations including pre-processing, test-train dataset split, cross validation, variable importance, and class imbalance are described in detail in the supplementary material.
Results
Capsule endoscopy findings
147 FDRs underwent VCE: in 144 the caecum was reached. There was one capsule retention, managed conservatively with prokinetic agents. The commonest abnormal finding was of small aphthous ulceration in the distal ileum, and no strictures were identified. Marked inflammation typical of CD (>150 aphthous ulcers throughout the small intestine) was found in only one FDR, in the high risk group.
94% of the lowest risk group had no SI inflammation (Lewis score <135) compared with 68% of the highest risk group (p=0.0001). In the highest risk group, 9% had moderate-severe inflammation (Lewis score ≥790) compared with none in the low risk group (p=0.016).
Characteristics of the highest and lowest risk quartiles
In total, 124 of the 147 FDRs who underwent VCE had complete study data and are included in all analyses. CD family history (binary-coded "single" or "multiple"), and genetic risk score (supplementary Table S4 ). Although stepwise selection achieves a reduction in the number of predictor variables, and can quantify the variance in the outcome explained by the predictors, these classic statistical approaches do not account for correlation among predictors (supplementary Figure S1 ) and provide no indication of the predictive ability of the derived model.
Predictive modelling
Predictive models were built on a training sample of 83 FDRs (2/3 of the data), and predictive ability assessed on the test sample of 41 FDRs (remaining 1/3 of the data).
The predictive performance of the random forest (AUC=0.87, 95% CI=0.75 -1.00;
Accuracy=0.73, 95% CI=0.57 -0.86) was slightly better than the elastic net 16 (AUC=0. Note. Final model parameter values: elastic net α=0.25, λ=0.50, and the random forest mtry = 14 (number of randomly selected predictors). Predictor importance Table 4 shows the predictors selected by the elastic net and their relative importance in both classifiers. The elastic net reduced the full set of predictors to CD family history (OR=1.31), genetic risk score (OR=1. 14) , and FC (OR=1.04), which are the same 3 predictors selected by stepwise BIC (supplementary Table S4 ). There is no acceptable way to assign p-values or confidence intervals to individual predictors in a cross-validated elastic net solution as standard approaches ignore "the complex selection procedure for defining the reduced model in the first place" 31 . Beyond the standard clinical predictors (family history and FC), genetic risk provided additional predictive utility. Note. Only top 5 predictors shown for the random forest. The random forest importance is the mean decrease in accuracy given by the difference in error rate after permuting the particular variable, averaged over all trees. The elastic net importance is the absolute value of the regression coefficient t-statistic.
Genetic risk score improves predictive performance
Genetic risk score was one of three variables selected by the elastic net and ranked the second most important predictor by both classifiers. However, it is still relevant to determine how much additional predictive value genetic risk adds. A model built on all variables excluding genetic risk score produced a lower AUC (0.78, 95% CI: 0.55 -1.00, p=0.0071) based on two variables: FC (OR=1.09) and CD family history (OR=1.63), compared to the full elastic net model AUC (0.80, 95% CI=0.62 -0.98, p=0.0039 (Mann-Whitney U test derived 32 )).
Conclusion
In our sample of 124 asymptomatic FDRs, we found that the combination of number of CD-affected relatives, genetic risk score, and level of FC made a good predictor of SI inflammation. The elastic net and random forest classifiers performed similarly, with significant above-chance prediction of SI inflammation.
The two models assume a different relationship between predictors and outcome: elastic net combines predictors linearly, whereas random forest makes multiple binary splits of the observations on one predictor at a time. In the elastic net, it is the combined set of selected predictors that captures the variance explained by correlated factors not selected. For example, the elastic net did not select smoking.
This does not suggest smoking is any less important as a risk factor for the disease but is simply a product of the study design and the correlational pattern of the particular predictors included. The random forest, which by design does not exclude predictors, ranked smoking among the top 10 most important variables. Given the different design of the classifiers, there is no expectation that they should agree.
However, that their results converge -CD family history, genetic risk score, and FC appeared among the top 5 predictors of the random forest -increases confidence in the utility of the particular set of predictors included.
CD family history was the strongest predictor in the elastic net model, and ranked 5 th most important predictor in the random forest. A retrospective study of the entire Danish population followed for a 44-year period found that the incidence rate for IBD was increased among individuals with two or more affected relatives 2 . By design, all our study participants had at least one relative with CD; we found that having a stronger family history (two or more relatives with CD) increased the risk for SI inflammation. It is worth noting that although studies often include the raw number of affected family members as a risk factor, it is a crude measure of familial risk.
Ideally, total family size, structure, and age of affected individuals as well as raw count should be incorporated in a measure of "family history" 33 .
We found that 44 of 124 FDRs (35%) had abnormally elevated FC (≥50 μg/g, usually indicative of intestinal pathology 12 ). Asymptomatic FDRs with increased FC have previously been observed 12 . Given that FC is part of the diagnostic work-up for CD 10 , and increased levels predict relapse 34 , our finding of the predictive utility of FC for SI inflammation suggest it is a promising biomarker for detecting those at greatest risk for CD. However, using a cut-off of ≥50 μg/g might include too many false positivesa cut-off of >250 μg/g may be a more appropriate level for a screening tool in asymptomatic individuals as this correlates with active CD 35 .
Genetic risk score was a significant predictor of SI inflammation. The predictive accuracy of our elastic net classifiers with or without genotype were both within the 0.7-0.8 range generally considered to be "acceptable discrimination" 36 . One way to evaluate the added value of genetic risk score is to consider what difference it might make in clinical practice. Our estimates showed a 2-percentage point increase in AUC on inclusion of genetic risk. Given that AUC is the probability that in a randomly selected case-control pair the case will be assigned a higher risk score, the model including genetic risk score accurately predicts an additional 2 cases in every 100 randomly selected pairs over the model without genetic risk. Updating the genetic risk panel as more risk loci are discovered is likely to increase the performance of the model further, and would be feasible now that low cost genome-wide SNP arrays are available which provide good coverage of known common IBD risk variants.
Mild SI inflammation found at VCE has been reported in 24% of asymptomatic FDRs, but the subsequent development of CD was not determined 37 . A study of 38 FDRs who underwent ileocolonoscopy found mild endoscopic and histological inflammation in 26% and CD in 13%. Those with mild inflammation were followed up with repeat ileocolonoscopy after a mean of 53 months without endoscopic or histological progression of inflammation 13 . In our study 26/124 (21%) of FDRs had abnormal Lewis scores, which is broadly consistent with these data. Long term follow-up of our FDR cohort is planned (out to 10 years), and may provide further information regarding risk of developing overt CD as opposed to asymptomatic SI inflammation. It is not yet certain whether these features are predictive of future development of CD, or are simply a spectrum of the "at-risk" individual who has not had the necessary environmental exposure(s) required to develop disease.
Progression to CD in cases of isolated terminal ileitis found at ileocolonoscopy in the general population is not clear-cut, largely due to small study sample sizes, short duration of follow-up, heterogeneity of symptoms, and retrospective study design.
Nevertheless, the rate appears to be low: 1% in a study with a mean follow-up of 29.9 months 38 ,and 5% in another with a median follow-up of 97.5 months. 39 .
Although we used an unseen subset of samples (set aside from the full sample) to test the predictive performance of our model, this test sample was subject to the same design decisions as the training samples, as well as any study-specific idiosyncrasies. Ultimately our finding will require external validation, i.e., replication in a completely independent sample. We included 72 CD-associated genetic variants known at the time of clinical assessment 16 , and the single best-understood lifestyle factor, smoking. A replication could benefit from the inclusion of the up-to-date list of 240 IBD-associated SNPs 7 (given that most IBD loci confer risk for both CD and UC 40 ), and a more comprehensive picture of the environmental risk (i.e., in addition to smoking, medication, diet, stress, sleep, physical activity 9 ). Finally, this study did not assess the gut microbiome, a likely predictor of risk for CD and potential target for intervention. The Genetic, Environmental and Microbiome (GEM) Project, currently recruiting 5000 CD FDRs internationally, will hopefully bring further insights into pre-clinical CD with the combination of all of these factors 41 .
In parallel with our increasing understanding of the specific genetic and environmental risk factors that combine to make an individual's immune system hostile to commensal gut flora, a clinically useful tool for detecting those at greatest risk for CD before the presentation of overt symptoms would prioritise patient screening and follow up. Early detection opens up the possibility for early intervention, additional targets for drug development, and disease prevention. Our study suggests that a CD prediction tool can be built from a small set of biomarkers, known genetic risk variants, and family history of CD. Inclusion of risk factors from the most recent findings will improve prediction accuracy.
Ethical approval & consent
Ethical approval was granted by Health Research Authority, UK (10/H0710/011) and all participants provided their written informed consent.
Funding
